Request for Covid-19 Impact Assessment of this Report
The United States DTP Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global DTP Vaccine market, reaching US$ million by the year 2028. As for the Europe DTP Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main DTP Vaccine players cover SANOFI PASTEUR, NOVARTIS, Vaxelis, and GSK, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of DTP Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Pertussis
Diphtheria
Tetanus
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Epidemic Prevention Station
Village Health Room
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
SANOFI PASTEUR
NOVARTIS
Vaxelis
GSK
Serum Institute of India
Johnson & Johnson
Merck Sharp & Dohme Corp
Seqirus
Pfizer
Astrazeneca
astellas
Emergent BioSolutions Inc
WALVAX
Wuhan Institute of Biological Products Co.,Ltd.
Chengdu Institute of Biological Products Co.,Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global DTP Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for DTP Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for DTP Vaccine by Country/Region, 2017, 2022 & 2028
2.2 DTP Vaccine Segment by Type
2.2.1 Pertussis
2.2.2 Diphtheria
2.2.3 Tetanus
2.3 DTP Vaccine Sales by Type
2.3.1 Global DTP Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global DTP Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global DTP Vaccine Sale Price by Type (2017-2022)
2.4 DTP Vaccine Segment by Application
2.4.1 Hospital
2.4.2 Epidemic Prevention Station
2.4.3 Village Health Room
2.5 DTP Vaccine Sales by Application
2.5.1 Global DTP Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global DTP Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global DTP Vaccine Sale Price by Application (2017-2022)
3 Global DTP Vaccine by Company
3.1 Global DTP Vaccine Breakdown Data by Company
3.1.1 Global DTP Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global DTP Vaccine Sales Market Share by Company (2020-2022)
3.2 Global DTP Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global DTP Vaccine Revenue by Company (2020-2022)
3.2.2 Global DTP Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global DTP Vaccine Sale Price by Company
3.4 Key Manufacturers DTP Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DTP Vaccine Product Location Distribution
3.4.2 Players DTP Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for DTP Vaccine by Geographic Region
4.1 World Historic DTP Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global DTP Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global DTP Vaccine Annual Revenue by Geographic Region
4.2 World Historic DTP Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global DTP Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global DTP Vaccine Annual Revenue by Country/Region
4.3 Americas DTP Vaccine Sales Growth
4.4 APAC DTP Vaccine Sales Growth
4.5 Europe DTP Vaccine Sales Growth
4.6 Middle East & Africa DTP Vaccine Sales Growth
5 Americas
5.1 Americas DTP Vaccine Sales by Country
5.1.1 Americas DTP Vaccine Sales by Country (2017-2022)
5.1.2 Americas DTP Vaccine Revenue by Country (2017-2022)
5.2 Americas DTP Vaccine Sales by Type
5.3 Americas DTP Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DTP Vaccine Sales by Region
6.1.1 APAC DTP Vaccine Sales by Region (2017-2022)
6.1.2 APAC DTP Vaccine Revenue by Region (2017-2022)
6.2 APAC DTP Vaccine Sales by Type
6.3 APAC DTP Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe DTP Vaccine by Country
7.1.1 Europe DTP Vaccine Sales by Country (2017-2022)
7.1.2 Europe DTP Vaccine Revenue by Country (2017-2022)
7.2 Europe DTP Vaccine Sales by Type
7.3 Europe DTP Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa DTP Vaccine by Country
8.1.1 Middle East & Africa DTP Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa DTP Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa DTP Vaccine Sales by Type
8.3 Middle East & Africa DTP Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DTP Vaccine
10.3 Manufacturing Process Analysis of DTP Vaccine
10.4 Industry Chain Structure of DTP Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DTP Vaccine Distributors
11.3 DTP Vaccine Customer
12 World Forecast Review for DTP Vaccine by Geographic Region
12.1 Global DTP Vaccine Market Size Forecast by Region
12.1.1 Global DTP Vaccine Forecast by Region (2023-2028)
12.1.2 Global DTP Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global DTP Vaccine Forecast by Type
12.7 Global DTP Vaccine Forecast by Application
13 Key Players Analysis
13.1 SANOFI PASTEUR
13.1.1 SANOFI PASTEUR Company Information
13.1.2 SANOFI PASTEUR DTP Vaccine Product Offered
13.1.3 SANOFI PASTEUR DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 SANOFI PASTEUR Main Business Overview
13.1.5 SANOFI PASTEUR Latest Developments
13.2 NOVARTIS
13.2.1 NOVARTIS Company Information
13.2.2 NOVARTIS DTP Vaccine Product Offered
13.2.3 NOVARTIS DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 NOVARTIS Main Business Overview
13.2.5 NOVARTIS Latest Developments
13.3 Vaxelis
13.3.1 Vaxelis Company Information
13.3.2 Vaxelis DTP Vaccine Product Offered
13.3.3 Vaxelis DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Vaxelis Main Business Overview
13.3.5 Vaxelis Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK DTP Vaccine Product Offered
13.4.3 GSK DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Serum Institute of India
13.5.1 Serum Institute of India Company Information
13.5.2 Serum Institute of India DTP Vaccine Product Offered
13.5.3 Serum Institute of India DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Serum Institute of India Main Business Overview
13.5.5 Serum Institute of India Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson DTP Vaccine Product Offered
13.6.3 Johnson & Johnson DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Merck Sharp & Dohme Corp
13.7.1 Merck Sharp & Dohme Corp Company Information
13.7.2 Merck Sharp & Dohme Corp DTP Vaccine Product Offered
13.7.3 Merck Sharp & Dohme Corp DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Sharp & Dohme Corp Main Business Overview
13.7.5 Merck Sharp & Dohme Corp Latest Developments
13.8 Seqirus
13.8.1 Seqirus Company Information
13.8.2 Seqirus DTP Vaccine Product Offered
13.8.3 Seqirus DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Seqirus Main Business Overview
13.8.5 Seqirus Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer DTP Vaccine Product Offered
13.9.3 Pfizer DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Astrazeneca
13.10.1 Astrazeneca Company Information
13.10.2 Astrazeneca DTP Vaccine Product Offered
13.10.3 Astrazeneca DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Astrazeneca Main Business Overview
13.10.5 Astrazeneca Latest Developments
13.11 astellas
13.11.1 astellas Company Information
13.11.2 astellas DTP Vaccine Product Offered
13.11.3 astellas DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 astellas Main Business Overview
13.11.5 astellas Latest Developments
13.12 Emergent BioSolutions Inc
13.12.1 Emergent BioSolutions Inc Company Information
13.12.2 Emergent BioSolutions Inc DTP Vaccine Product Offered
13.12.3 Emergent BioSolutions Inc DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Emergent BioSolutions Inc Main Business Overview
13.12.5 Emergent BioSolutions Inc Latest Developments
13.13 WALVAX
13.13.1 WALVAX Company Information
13.13.2 WALVAX DTP Vaccine Product Offered
13.13.3 WALVAX DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 WALVAX Main Business Overview
13.13.5 WALVAX Latest Developments
13.14 Wuhan Institute of Biological Products Co.,Ltd.
13.14.1 Wuhan Institute of Biological Products Co.,Ltd. Company Information
13.14.2 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product Offered
13.14.3 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Wuhan Institute of Biological Products Co.,Ltd. Main Business Overview
13.14.5 Wuhan Institute of Biological Products Co.,Ltd. Latest Developments
13.15 Chengdu Institute of Biological Products Co.,Ltd.
13.15.1 Chengdu Institute of Biological Products Co.,Ltd. Company Information
13.15.2 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product Offered
13.15.3 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Chengdu Institute of Biological Products Co.,Ltd. Main Business Overview
13.15.5 Chengdu Institute of Biological Products Co.,Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. DTP Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. DTP Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Pertussis
Table 4. Major Players of Diphtheria
Table 5. Major Players of Tetanus
Table 6. Global DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 7. Global DTP Vaccine Sales Market Share by Type (2017-2022)
Table 8. Global DTP Vaccine Revenue by Type (2017-2022) & ($ million)
Table 9. Global DTP Vaccine Revenue Market Share by Type (2017-2022)
Table 10. Global DTP Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 12. Global DTP Vaccine Sales Market Share by Application (2017-2022)
Table 13. Global DTP Vaccine Revenue by Application (2017-2022)
Table 14. Global DTP Vaccine Revenue Market Share by Application (2017-2022)
Table 15. Global DTP Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global DTP Vaccine Sales by Company (2020-2022) & (K Units)
Table 17. Global DTP Vaccine Sales Market Share by Company (2020-2022)
Table 18. Global DTP Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 19. Global DTP Vaccine Revenue Market Share by Company (2020-2022)
Table 20. Global DTP Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers DTP Vaccine Producing Area Distribution and Sales Area
Table 22. Players DTP Vaccine Products Offered
Table 23. DTP Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global DTP Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global DTP Vaccine Sales Market Share Geographic Region (2017-2022)
Table 28. Global DTP Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global DTP Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global DTP Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global DTP Vaccine Sales Market Share by Country/Region (2017-2022)
Table 32. Global DTP Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global DTP Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas DTP Vaccine Sales by Country (2017-2022) & (K Units)
Table 35. Americas DTP Vaccine Sales Market Share by Country (2017-2022)
Table 36. Americas DTP Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas DTP Vaccine Revenue Market Share by Country (2017-2022)
Table 38. Americas DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 39. Americas DTP Vaccine Sales Market Share by Type (2017-2022)
Table 40. Americas DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 41. Americas DTP Vaccine Sales Market Share by Application (2017-2022)
Table 42. APAC DTP Vaccine Sales by Region (2017-2022) & (K Units)
Table 43. APAC DTP Vaccine Sales Market Share by Region (2017-2022)
Table 44. APAC DTP Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC DTP Vaccine Revenue Market Share by Region (2017-2022)
Table 46. APAC DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 47. APAC DTP Vaccine Sales Market Share by Type (2017-2022)
Table 48. APAC DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 49. APAC DTP Vaccine Sales Market Share by Application (2017-2022)
Table 50. Europe DTP Vaccine Sales by Country (2017-2022) & (K Units)
Table 51. Europe DTP Vaccine Sales Market Share by Country (2017-2022)
Table 52. Europe DTP Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe DTP Vaccine Revenue Market Share by Country (2017-2022)
Table 54. Europe DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 55. Europe DTP Vaccine Sales Market Share by Type (2017-2022)
Table 56. Europe DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Europe DTP Vaccine Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa DTP Vaccine Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa DTP Vaccine Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa DTP Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa DTP Vaccine Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa DTP Vaccine Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa DTP Vaccine Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa DTP Vaccine Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa DTP Vaccine Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of DTP Vaccine
Table 67. Key Market Challenges & Risks of DTP Vaccine
Table 68. Key Industry Trends of DTP Vaccine
Table 69. DTP Vaccine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. DTP Vaccine Distributors List
Table 72. DTP Vaccine Customer List
Table 73. Global DTP Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global DTP Vaccine Sales Market Forecast by Region
Table 75. Global DTP Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global DTP Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas DTP Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas DTP Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC DTP Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC DTP Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe DTP Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe DTP Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa DTP Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa DTP Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global DTP Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global DTP Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 87. Global DTP Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global DTP Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global DTP Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global DTP Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 91. Global DTP Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global DTP Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 93. SANOFI PASTEUR Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. SANOFI PASTEUR DTP Vaccine Product Offered
Table 95. SANOFI PASTEUR DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. SANOFI PASTEUR Main Business
Table 97. SANOFI PASTEUR Latest Developments
Table 98. NOVARTIS Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. NOVARTIS DTP Vaccine Product Offered
Table 100. NOVARTIS DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. NOVARTIS Main Business
Table 102. NOVARTIS Latest Developments
Table 103. Vaxelis Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Vaxelis DTP Vaccine Product Offered
Table 105. Vaxelis DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Vaxelis Main Business
Table 107. Vaxelis Latest Developments
Table 108. GSK Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. GSK DTP Vaccine Product Offered
Table 110. GSK DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. GSK Main Business
Table 112. GSK Latest Developments
Table 113. Serum Institute of India Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Serum Institute of India DTP Vaccine Product Offered
Table 115. Serum Institute of India DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Serum Institute of India Main Business
Table 117. Serum Institute of India Latest Developments
Table 118. Johnson & Johnson Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Johnson & Johnson DTP Vaccine Product Offered
Table 120. Johnson & Johnson DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Johnson & Johnson Main Business
Table 122. Johnson & Johnson Latest Developments
Table 123. Merck Sharp & Dohme Corp Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Merck Sharp & Dohme Corp DTP Vaccine Product Offered
Table 125. Merck Sharp & Dohme Corp DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Merck Sharp & Dohme Corp Main Business
Table 127. Merck Sharp & Dohme Corp Latest Developments
Table 128. Seqirus Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Seqirus DTP Vaccine Product Offered
Table 130. Seqirus DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Seqirus Main Business
Table 132. Seqirus Latest Developments
Table 133. Pfizer Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Pfizer DTP Vaccine Product Offered
Table 135. Pfizer DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Pfizer Main Business
Table 137. Pfizer Latest Developments
Table 138. Astrazeneca Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Astrazeneca DTP Vaccine Product Offered
Table 140. Astrazeneca DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Astrazeneca Main Business
Table 142. Astrazeneca Latest Developments
Table 143. astellas Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. astellas DTP Vaccine Product Offered
Table 145. astellas DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. astellas Main Business
Table 147. astellas Latest Developments
Table 148. Emergent BioSolutions Inc Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Emergent BioSolutions Inc DTP Vaccine Product Offered
Table 150. Emergent BioSolutions Inc DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Emergent BioSolutions Inc Main Business
Table 152. Emergent BioSolutions Inc Latest Developments
Table 153. WALVAX Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. WALVAX DTP Vaccine Product Offered
Table 155. WALVAX DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. WALVAX Main Business
Table 157. WALVAX Latest Developments
Table 158. Wuhan Institute of Biological Products Co.,Ltd. Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 159. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product Offered
Table 160. Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Wuhan Institute of Biological Products Co.,Ltd. Main Business
Table 162. Wuhan Institute of Biological Products Co.,Ltd. Latest Developments
Table 163. Chengdu Institute of Biological Products Co.,Ltd. Basic Information, DTP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 164. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product Offered
Table 165. Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Chengdu Institute of Biological Products Co.,Ltd. Main Business
Table 167. Chengdu Institute of Biological Products Co.,Ltd. Latest Developments
List of Figures
Figure 1. Picture of DTP Vaccine
Figure 2. DTP Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DTP Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global DTP Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. DTP Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Pertussis
Figure 10. Product Picture of Diphtheria
Figure 11. Product Picture of Tetanus
Figure 12. Global DTP Vaccine Sales Market Share by Type in 2021
Figure 13. Global DTP Vaccine Revenue Market Share by Type (2017-2022)
Figure 14. DTP Vaccine Consumed in Hospital
Figure 15. Global DTP Vaccine Market: Hospital (2017-2022) & (K Units)
Figure 16. DTP Vaccine Consumed in Epidemic Prevention Station
Figure 17. Global DTP Vaccine Market: Epidemic Prevention Station (2017-2022) & (K Units)
Figure 18. DTP Vaccine Consumed in Village Health Room
Figure 19. Global DTP Vaccine Market: Village Health Room (2017-2022) & (K Units)
Figure 20. Global DTP Vaccine Sales Market Share by Application (2017-2022)
Figure 21. Global DTP Vaccine Revenue Market Share by Application in 2021
Figure 22. DTP Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 23. Global DTP Vaccine Revenue Market Share by Company in 2021
Figure 24. Global DTP Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global DTP Vaccine Revenue Market Share by Geographic Region in 2021
Figure 26. Global DTP Vaccine Sales Market Share by Region (2017-2022)
Figure 27. Global DTP Vaccine Revenue Market Share by Country/Region in 2021
Figure 28. Americas DTP Vaccine Sales 2017-2022 (K Units)
Figure 29. Americas DTP Vaccine Revenue 2017-2022 ($ Millions)
Figure 30. APAC DTP Vaccine Sales 2017-2022 (K Units)
Figure 31. APAC DTP Vaccine Revenue 2017-2022 ($ Millions)
Figure 32. Europe DTP Vaccine Sales 2017-2022 (K Units)
Figure 33. Europe DTP Vaccine Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa DTP Vaccine Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa DTP Vaccine Revenue 2017-2022 ($ Millions)
Figure 36. Americas DTP Vaccine Sales Market Share by Country in 2021
Figure 37. Americas DTP Vaccine Revenue Market Share by Country in 2021
Figure 38. United States DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC DTP Vaccine Sales Market Share by Region in 2021
Figure 43. APAC DTP Vaccine Revenue Market Share by Regions in 2021
Figure 44. China DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 48. India DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe DTP Vaccine Sales Market Share by Country in 2021
Figure 51. Europe DTP Vaccine Revenue Market Share by Country in 2021
Figure 52. Germany DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. France DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa DTP Vaccine Sales Market Share by Country in 2021
Figure 58. Middle East & Africa DTP Vaccine Revenue Market Share by Country in 2021
Figure 59. Egypt DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country DTP Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of DTP Vaccine in 2021
Figure 65. Manufacturing Process Analysis of DTP Vaccine
Figure 66. Industry Chain Structure of DTP Vaccine
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...